(Wilton, CT (PRWEB) January 10, 2012)
Quote (but it is much more info on the site):
A Lyme disease grant has also been awarded to Dr. Tara Moriarty of the University of Toronto, who will investigate the possible role of metabolic syndrome in some cases of unresolved Lyme disease. Metabolic syndrome is a combination of clinical factors that increase the risk of cardiovascular disease and diabetes, and its incidence has grown dramatically over the last few decades. Preliminary work in Dr. Moriarty’s lab indicates that when mice are given a high fat diet that induces atherosclerosis, obesity and hyperglycemia, they experience a higher burden of infection when exposed to B. burgdorferi than do mice with normal metabolism. Dr. Moriarty will continue this work in an attempt to tease out the specific metabolic factors that increase host susceptibility to disseminated Lyme disease; this may lead to novel treatments for human patients with unresolved illness.